Cisplatin Part 1

(13:48)

Cisplatin Part 4

(12:27)

Cisplatin Part 2

(13:6)

Cisplatin Part 5

(8:45)

Cisplatin Part 3

(20:4)

Cisplatin | RMIT University

(3:25)

Clisplatin - Mechanism of Action

(32)

Neoadjuvant Cisplatin-Based Chemotherapy for Muscle Invasive Bladder Cancer

(5:25)

3-weekly cisplatin or weekly cisplatin for squamous cell carcinoma of head and neck

(5:39)

Cisplatin-Ineligible Treatment Options for Advanced Bladder Cancer - Bladder Cancer Video Library

(4:50)

A promising future for gemcitabine-oxaliplatin in cisplatin-unfit advanced urothelial carcinoma

(1:27)

Evaluating options for HPV+ oropharyngeal cancer: cisplatin-RT vs. cetuximab-RT

(1:23)

Refining Chemoradiation for Advanced HNSCC

(7:25)

Cisplatin +/- veliparib in metastatic TNBC and/or germline BRCA-associated breast cancer

(3:36)

Cisplatin Discovery: Survivor John Cleland

(44)

Adjuvant Chemotherapy for Elderly and Frail Patients Part 2v

(6:30)

Cisplatin-Based Therapy in Muscle-Invasive Bladder Cancer

(7:2)

SWOG 1815: gemcitabine, cisplatin, and nab-paclitaxel in biliary tract cancer

(1:59)

KEYNOTE-966: pembrolizumab, gemcitabine and cisplatin for CCA

(3:39)

Mechanism of Cisplatin - Chemotherapy

(4:39)